Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
A study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
BulgariaStudy of navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
AustriaComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
BulgariaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
GermanyStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
CzechiaStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
AustriaStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
BelgiumStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
BelgiumStudy of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis
BelgiumStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
